Opinion
Video
Author(s):
Max Kates, MD, discusses how BCG-unresponsive non-muscle invasive bladder cancer patients historically faced limited treatment options beyond radical cystectomy, with significant unmet needs in preserving bladder function while effectively treating this aggressive disease.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.